Re: in vivo and in vitro effects of xenogeneic immune ribonucleic acid in patients with advanced renal cell carcinoma: a phase I study.
D000230:Adenocarcinoma / Q000628:therapy*; D004341:Drug Evaluation; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D012313:RNA / Q000276:immunology* / Q000627:therapeutic use
C013674:RNA, immune; D012313:RNA